Abstracts - faqs.org

Abstracts

News, opinion and commentary

Search abstracts:
Abstracts » News, opinion and commentary

Counsel to sell unit after ditching IPO

Article Abstract:

Counsel Corp., a Toronto, Ontario-based holding company, is selling its Pittsburgh, PA-based wholly owned subsidiary Stadtlander Drug Company Inc. to Bergen Brunswig Corp. for an estimated $315 million in cash and stock deal. The move comes after Counsel withdrew from its plans of making an initial public offering. Under the terms of the deal, Counsel will get three million Bergen shares worth at least $150 million as of January 1998, and up to $165 million in cash. Orange, CA-based Bergen will also assume Stadtlander's debt of around $100 million. Bergen is a distributor of pharmaceuticals and medical-surgical supplies to hospitals, pharmacies and supermarkets, while Stadtlander takes care of pharmaceutical needs of patients with high-risk and high-cost medical conditions.

Comment:

Is buying Counsel Corp's wholly owned subsidiary, Stadtlander Drug Co Inc, for around $315 mil in cash & stock deal

Author: Zehr, Leonard
Publisher: Bell Globemedia Interactive
Publication Name: Globe & Mail (Toronto, Canada)
Subject: News, opinion and commentary
ISSN: 0319-0714
Year: 1998
Pennsylvania, Drugs and Druggists' Sundries Wholesalers, Drugs, Cosmetics, Toiletries Whsle, Bergen Brunswig Corp., Article, Stadtlanders Drug Co., Counsel Corp.

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Hyal board accepts Cangene takeover offer

Article Abstract:

Cash-strapped Hyal Pharmaceutical Corp of Mississauga, Ontario, has accepted the takeover offer of Cangene Corp. Under the deal, Cangene will provide Hyall with up to C$350,000 of interim financing on a secured basis. Cangene has offered in July 1999 to acquire all of Hyal's 31 million shares outstanding for 8 cents a share or around C$2.5 million. Hyal accepted the offer after failing to get other measures to avoid bankruptcy or liquidation proceedings.

Author: Zehr, Leonard
Publisher: Bell Globemedia Interactive
Publication Name: Globe & Mail (Toronto, Canada)
Subject: News, opinion and commentary
ISSN: 0319-0714
Year: 1999
Canada, Pharmaceutical Preparation Manufacturing, Pharmaceutical Preparations, Drugs, Hyal Pharmaceutical Corp.

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Similar abstracts:
  • Abstracts: Bre-X unit to merge with oil company. RealFund head rejects RioCan takeover bid
  • Abstracts: Sun Media vows to fight Star bid. Sun Media board unanimously rejects Torstar offer. Hollinger sells shares to redeem LYONs
  • Abstracts: Court refuses bid to appeal Sun Life deal. Money-losing GAN Canada up for sale. Two more raters go negative on Sun Life
  • Abstracts: Sun directors advise shareholders to sit tight on Torstar takeover bid. Calgary Herald files defamation suit against union
  • Abstracts: Hudson's Bay to reap another kind of reward from loyalty programs. New worries beset Eaton's struggle for survival
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.